Fig. 3.
Local and systemic potentiation of ECT by CpG ODN in the B16OVA melanoma. Mice were inoculated with 5.105 B16OVA cells on each side and were only treated on the left side when the tumor reached 5 mm diameter. ECT was performed as a single session treatment at day zero. A dose of 50 μg of CpG ODN was delivered into the left tumors at days 2 and 9. Results show the monitoring of the treated tumors (a) and the non-treated tumors (b) in a representative experiment out of two (n = 7 per group, *P < 0.05)